Search all trials

Find therapies in clinical trials near you – page 15

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Hormone-refractory prostate cancer

Not recruiting

Registered drugNo placebo

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Anti-neutrophil cytoplasmic antibody positive vasculitis

Not recruiting

Registered drugNo placebo

Study on Avacopan with Rituximab or Cyclophosphamide for Children Aged 6 to 17 with Active ANCA-associated Vasculitis

Registered drugNo placebo

Slovakia

Participants:0–17 years
Substances:Avacopan

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Everolimus

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Registered drugNo placebo

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Registered drugNo placebo

Slovakia

Participants:18–64 years · 65+ years
Substances:Acalabrutinib

Contact Research Centre

Colorectal cancer metastatic+1

Not recruiting

Registered drugNo placebo

Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

Registered drugNo placebo

Slovakia

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cetuximab

Contact Research Centre

Prostate cancer

Not recruiting

Registered drug

Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Multiple sclerosis relapse

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

Registered drugNo placebo

Slovakia

Participants:18–64 years
Substances:Ofatumumab

Contact Research Centre

IgA nephropathy

Not recruiting

Investigational

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Investigational

Slovakia

Participants:18–64 years · 65+ years
Substances:Iptacopan

Contact Research Centre

Pulmonary arterial hypertension

Not recruiting

Registered drug

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Registered drug

Slovakia

Participants:18–64 years · 65+ years
Substances:Macitentan

Contact Research Centre

Relapsing multiple sclerosis

Not recruiting

Investigational

Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

Investigational

Slovakia

Participants:18–64 years

Contact Research Centre

Find therapies in clinical trials near you – page 15

276 trials match your criteria

Hormone-refractory prostate cancer

Study Comparing BMS-986365 with Other Treatments for Patients with Metastatic Castration-resistant Prostate Cancer

Breast cancer+1

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Anti-neutrophil cytoplasmic antibody positive vasculitis

Study on Avacopan with Rituximab or Cyclophosphamide for Children Aged 6 to 17 with Active ANCA-associated Vasculitis

Colitis ulcerative

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis

Breast cancer+1

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Chronic lymphocytic leukaemia

Study on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation

Colorectal cancer metastatic+1

Study of Encorafenib, Cetuximab, and Pembrolizumab for Patients with Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer

Prostate cancer

Study on Enzalutamide and Leuprorelin Acetate for Men with High-Risk Nonmetastatic Prostate Cancer After Treatment

Multiple sclerosis relapse

Study on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis

IgA nephropathy

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Pulmonary arterial hypertension

Study Comparing the Effectiveness and Safety of Macitentan 75 mg and 10 mg for Patients with Pulmonary Arterial Hypertension

Relapsing multiple sclerosis

Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.